Summary
Definition
Anamnesis y examen
Principales factores de diagnóstico
- presencia de factores de riesgo
- dolor localizado en un dermatoma
- prurito
- erupción
- ulceración corneal
Otros factores de diagnóstico
- fiebre
- cefalea
- malestar general
- fatiga
- dolor sin erupción
Factores de riesgo
- >50 años de edad
- sexo femenino
- VIH
- uso crónico de corticosteroides
- quimioterapia
- neoplasias malignas
- raza blanca
- determinadas afecciones agudas o crónicas
- vacunación contra otras enfermedades infecciosas
Pruebas diagnósticas
Primeras pruebas diagnósticas para solicitar
- diagnóstico clínico
Pruebas diagnósticas que deben considerarse
- reacción en cadena de la polimerasa (PCR)
- inmunohistoquímica
- cultivo del líquido vesicular
- prueba del VIH
Algoritmo de tratamiento
síntomas agudos: inmunocompetente
dolor posherpético
Colaboradores
Autores
Phuc Le, PhD, MPH
Assistant Professor
Center for Value-Based Care Research
Medicine Institute
Cleveland Clinic
Cleveland
OH
Divulgaciones
PL declares that she has no competing interests.
Michael Rothberg, MD, MPH
Professor
Center for Value-Based Care Research
Medicine Institute
Cleveland Clinic
Cleveland
OH
Disclosures
MR declares that he has no competing interests.
Acknowledgements
Dr Phuc Le and Dr Michael Rothberg would like to gratefully acknowledge Dr Kenneth J. Smith and Dr Linda Kalilani, the previous contributors to this topic.
Disclosures
KJS and LK declare that they have no competing interests.
Peer reviewers
Julius Atashili, MD, MPH
Department of Epidemiology
Division of General Medicine and Epidemiology
UNC at Chapel Hill
Chapel Hill
NC
Declarações
JA declares that he has no competing interests.
Ken Mutton, MB, BS, FRCPA, FRCPath
Consultant Virologist
Manchester Royal Infirmary
Manchester
UK
Declarações
KM declares that he has no competing interests.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
Referências
Principais artigos
Dworkin RH, Johnson RW, Breuer J, et al. Recommendations for the management of herpes zoster. Clin Infect Dis. 2007 Jan 1;44 Suppl 1:S1-26.Texto completo Resumo
National Institutes of Health, Centers for Disease Control and Prevention, HIV Medicine Association, and Infectious Diseases Society of America. Panel on Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV: varicella-zoster virus. 2022 [internet publication].Texto completo
Dooling KL, Guo A, Patel M, et al. Recommendations of the Advisory Committee on Immunization Practices for use of herpes zoster vaccines. MMWR Morb Mortal Wkly Rep. 2018 Jan 26;67(3):103-8.Texto completo Resumo
Centers for Disease Control and Prevention. Adult immunization schedule by age. Recommendations for ages 19 years or older, United States, 2025. Nov 2024 [internet publication].Texto completo
Severson EA, Baratz KH, Hodge DO, et al. Herpes zoster ophthalmicus in Olmsted County, Minnesota: have systemic antivirals made a difference? Arch Ophthalmol. 2003 Mar;121(3):386-90.Texto completo Resumo
Artigos de referência
Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
Diagnósticos diferenciais
- Dermatitis de contacto
- Herpes simple
- Colecistitis
Mais Diagnósticos diferenciaisDiretrizes
- Shingles (herpes zoster): the green book, chapter 28a
- Recommended immunization schedule for adults aged 19 years or older: United States, 2025
Mais DiretrizesPatient information
Herpes zóster: ¿Qué es?
Herpes zóster: ¿Qué tratamientos funcionan?
More Patient information
Log in or subscribe to access all of BMJ Best Practice
Use of this content is subject to our disclaimer